Stockpickr Lists: Pharmion Soars on Trial Results

Editor's Note: In this feature from Stockpickr, we highlight lists of stocks that have made new highs, lows or seen other unusual activity.

Biggest % Gainers: Pharmion(PHRM) soared 58% after the company revealed positive phase III data for its Vidaza, a treatment for high-risk myelodysplastic syndromes. The drug performed well against conventional care regimens in the late-stage trial. Shares were up $14.42 at $439.06.

52-Week Highs: Shares of Pharmion also reached a 52-week high during Thursday trading.

Rising on Unusual Volume: Morningstar(MORN) increased 19.9% Thursday amid volume six times its three-month average after it reported very strong second-quarter earnings. Profits rose to $18.3 million, or 38 cents per share, from $11.2 million, or 24 cents per share, during the same quarter in 2006. The stock closed up $9.77 at $58.68.

Biggest % Losers: Pozen(POZN) sunk 43% after the Food and Drug Administration said it and partner GlaxoSmithKline(GSK) need to collect more safety data on their proposed migraine drug Trexima. The North Carolina-based company lost $7.52 to $9.93.

52-Week Lows: Getty Images(GYI) fell 19% to a 52-week low after it made a forecast for third-quarter profit and sales that fell below Wall Street's expectations. The company, which creates and distributes photos and other images, was down $8.70 at $36.14.

Latest Activist Situations: Ken Griffin's Citadel disclosed a 5.7% stake in Beazer Homes(BZH). This is up from the 1.2 million shares the firm held on March 31. Shares closed up 13.5% Thursday to $13.04.

Forum of the Day

What's the best investment at age 18? 03 black gt asks.

Do You Know the Answer?

Is covering long positions with puts feasible for small investors? Corgy asks.

Feeling Lucky?

And finally, try picking a random portfolio suited to do-it-yourselfers with more detailed analysis at I'm Feeling Lucky.

>To order reprints of this article, click here: Reprints